Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
1983-10-21
|
pubmed:abstractText |
The effect of tamoxifen on serum levels of basal prolactin and basal and stimulated growth hormone was assessed in 10 women with advanced breast cancer prior to and after 1 and 8 weeks of treatment. Tamoxifen had no effect on basal levels of either hormone or on insulin-stimulated growth hormone. Two of 4 patients undergoing arginine provocation testing had a partial response to tamoxifen and both exhibited marked diminution of growth hormone stimulation which was not seen in the non-responders.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0277-5379
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
19
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
919-22
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:6684048-Aged,
pubmed-meshheading:6684048-Arginine,
pubmed-meshheading:6684048-Breast Neoplasms,
pubmed-meshheading:6684048-Female,
pubmed-meshheading:6684048-Growth Hormone,
pubmed-meshheading:6684048-Humans,
pubmed-meshheading:6684048-Menopause,
pubmed-meshheading:6684048-Middle Aged,
pubmed-meshheading:6684048-Prolactin,
pubmed-meshheading:6684048-Tamoxifen
|
pubmed:year |
1983
|
pubmed:articleTitle |
The effect of tamoxifen on plasma growth hormone and prolactin in postmenopausal women with advanced breast cancer.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|